首页> 外国专利> AQUEOUS SUSPENSION CONTAINING MICROCRYSTALS OF PHARMACOLOGICALLY ACTIVE WATER-INSOLUBLE MEDICINAL SUBSTANCE AND COVERED WITH MEMBRANE-FORMING LIPID (VARIANTS) AND LYOPHILIZED PREPARATION OF AN AQUEOUS SUSPENSION

AQUEOUS SUSPENSION CONTAINING MICROCRYSTALS OF PHARMACOLOGICALLY ACTIVE WATER-INSOLUBLE MEDICINAL SUBSTANCE AND COVERED WITH MEMBRANE-FORMING LIPID (VARIANTS) AND LYOPHILIZED PREPARATION OF AN AQUEOUS SUSPENSION

机译:含药理活性水不溶性药物的微悬浊液,并包被有膜形成的脂质(变体),并经液化制备了悬浊液

摘要

FIELD: medicine, pharmacy. SUBSTANCE: an aqueous suspension has microcrystals of water-insoluble drug at solid state (diameter is 0.05-10 mcm) at amount 0.01-40 wt. -%/vol. Microcrystals are covered with the capsulating primary layer of lipid (thickness is 0.3-3 mcm). By the second variant microcrystals are covered with capsulating primary layer of lipid consisting of covering and enveloping layers and the following secondary layer (thickness is 25 nm-3 mcm) consisting of the indicated lipid in form of vesicles associated with microcrystals of drug surrounding their and distributed in suspending medium. Mass ratio of drug to lipid = (1:1)-(1000:1). Membrane-forming amphipatic lipid is phospholipid. Suspension is used for administration of high concentration of water-insoluble drug. EFFECT: improved property of suspension. 15 cl, 9 dwg, 6 tbl
机译:领域:医学,药学。物质:水性悬浮液具有固态(直径为0.05-10 mcm)的水不溶性药物微晶,含量为0.01-40 wt.。 -%/体积微晶被脂质的包囊性第一层所覆盖(厚度为0.3-3 mcm)。通过第二变体,微晶被脂质包囊的第一层覆盖,所述脂质的第一层由覆盖层和包封层组成,并且随后的第二层(厚度为25nm-3mcm)由指示的脂质形式的囊泡组成,其与围绕它们的药物微晶缔合分布在悬浮介质中。药物与脂质的质量比=(1:1)-(1000:1)。形成膜的两性脂质是磷脂。悬浮液用于高浓度水不溶性药物的给药。效果:改善了悬挂性能。 15厘升,9载重吨,6桶

著录项

  • 公开/公告号RU2100030C1

    专利类型

  • 公开/公告日1997-12-27

    原文格式PDF

  • 申请/专利权人 FARMA-LOGIK INK. (US);

    申请/专利号RU19920016352

  • 发明设计人 DUNKAN KH.KHEJNESUS;

    申请日1992-10-23

  • 分类号A61K38/00;A61K9/10;

  • 国家 RU

  • 入库时间 2022-08-22 02:45:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号